[Transfusion policy toward a patient with an anti-Cartwright antibody (anti-Yta)].
We have observed one patient with hepatic cirrhosis showing on her antibody screening an anti-Yta. We studied the 51 Cr-labelled erythrocyte survival using either Yt (a+) and autologous blood red cells. She was transfused two Yt (a+) red blood cell concentrates without any adverse reaction.
Arriaga
F
F
Servicio de Hematología y Hemoterapia, Hospital Universitario La Fe, Valencia.
García
R
R
Guinot
M
M
de la Rubia
J
J
García
M
M
Bonanad
S
S
Marty
M L
ML
D000368:Aged; D001789:Blood Group Antigens / Q000276:immunology*; D001787:Blood Group Incompatibility; D017707:Erythrocyte Transfusion; D004932:Esophageal and Gastric Varices / Q000150:complications; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000628:therapy; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D010438:Peptic Ulcer Hemorrhage / Q000150:complications / Q000628:therapy
D001789:Blood Group Antigens; D007518:Isoantibodies
Actitud transfusional frente a un paciente con un anticuerpo anti-Cartwright (anti-Yta).